Menu
MENU
Sign In   
Search
Sign In        
Home   >   Products

RDSI™

Reynolds Depression Screening Inventory™

William M. Reynolds, PhD, and Kenneth A. Kobak, PhD

Purpose:
Quickly screens for symptoms of depression
Format:
Paper and pencil
Age range:
18 years to 89 years
Time:
5-10 minutes to administer
Qualification level:
S
S
A degree, certificate, or license to practice in a health care profession or occupation, including (but not limited to) the following: medicine, neurology, nursing, occupational therapy and other allied health care professions, physician's assistants, psychiatry, social work; plus appropriate training and experience in the ethical administration, scoring, and interpretation of clinical behavioral assessment instruments. Certain health care providers may be eligible to purchase selected "B" and "C" level instruments within their area of expertise. Specifically, relevant supervised clinical experience using tests (i.e., internship, residency, etc.) in combination with formal coursework ( i.e., Tests and Measurement, Individual Assessment, or equivalent) qualifies a health care provider to purchase certain restricted products. Any PAR Customer already qualified to purchase a "B" or "C" level product, is also qualified to purchase an "S" level product. If you are not already qualified to purchase a "B"or "C" level product from PAR, please download and complete the special Qualification Form for Medical and Allied Health Professionals. (You will need Adobe Acrobat to view.) Close

The 19 items of the RDSI measure the severity of contemporary depressive symptoms. Although a formal diagnosis is not provided, empirically derived cutoff scores identify individuals who may be at risk for more serious, diagnostic forms of depression.

Quickly assesses DSM-IV™-specified symptomatology for major depressive disorder

  • Development sample consisted of 531 nonreferred community adults and 324 psychiatric outpatients (including 150 outpatients diagnosed with major depression).
  • Highly reliable and internally consistent, with high alpha coefficients (.93 and .90 for the community and psychiatric outpatient samples, respectively). Test-retest reliability of the RDSI also is very high (rtt = .94).
  • The RDSI showed a high correlation with the BDI® (r = .94) and the Hamilton Depression Rating Scale clinical interview (r = .93).
© 2000- by PAR, Inc., privately owned and operated since 1978. All rights reserved (2019-N). | Legal & Privacy Page | Manage Cookies